Swedish Orphan Biovitrum AB (SWOBY)
22.16
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Swedish Orphan Biovitrum Profit Margin (Quarterly) : 14.00% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.00% |
| March 31, 2026 | 18.35% |
| December 31, 2025 | 23.81% |
| September 30, 2025 | -37.23% |
| June 30, 2025 | 10.27% |
| March 31, 2025 | 13.53% |
| December 31, 2024 | 18.71% |
| September 30, 2024 | 21.24% |
| June 30, 2024 | 4.12% |
| March 31, 2024 | 12.79% |
| December 31, 2023 | 14.99% |
| September 30, 2023 | 1.82% |
| June 30, 2023 | 4.56% |
| March 31, 2023 | 20.37% |
| December 31, 2022 | 23.13% |
| September 30, 2022 | 11.28% |
| June 30, 2022 | 6.66% |
| March 31, 2022 | 11.03% |
| December 31, 2021 | 25.35% |
| September 30, 2021 | 12.58% |
| June 30, 2021 | 8.35% |
| March 31, 2021 | 19.01% |
| December 31, 2020 | 32.79% |
| September 30, 2020 | 9.36% |
| June 30, 2020 | 9.22% |
| Date | Value |
|---|---|
| March 31, 2020 | 25.48% |
| December 31, 2019 | 27.81% |
| September 30, 2019 | 18.50% |
| June 30, 2019 | 15.78% |
| March 31, 2019 | 27.66% |
| December 31, 2018 | 23.14% |
| September 30, 2018 | 26.91% |
| June 30, 2018 | 29.93% |
| March 31, 2018 | 26.22% |
| December 31, 2017 | 19.04% |
| September 30, 2017 | 20.24% |
| June 30, 2017 | 16.17% |
| March 31, 2017 | 14.47% |
| December 31, 2016 | 5.65% |
| September 30, 2016 | 11.53% |
| June 30, 2016 | 21.10% |
| March 31, 2016 | 23.64% |
| December 31, 2015 | -1.11% |
| September 30, 2015 | 0.64% |
| June 30, 2015 | 1.18% |
| March 31, 2015 | 12.25% |
| December 31, 2014 | -2.47% |
| September 30, 2014 | 7.91% |
| June 30, 2014 | 3.86% |
| March 31, 2014 | -57.33% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Hansa Biopharma AB | -541.7% |
| BioArctic AB | -4.51% |
| Diamyd Medical AB | -184.8K% |
| BONESUPPORT HOLDING AB | 23.02% |
| BioInvent International AB | -964.0% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 3.76% |
| Return on Assets | 2.00% |
| Return on Invested Capital | 2.73% |
| Gross Profit Margin (Quarterly) | 61.17% |
| Operating Margin (Quarterly) | 24.06% |
| Return on Net Operating Assets | 2.16% |